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Diabetic ketoacidosis (DKA) is one of the most frequent urgent and critical states in endocri-
nology. It results from diabetes mellitus decompensation provoked by various factors; notwith-
standing the improved general medical care and, especially, the care for diabetes mellitus pati-
ents DKA incidence rate remains relatively constant during the recent decades. Nowadays epi-
demiological investigations indicate that there are 43 cases to 10 000 diabetic mellitus patients. 
Mortality rate varies between 1 and 19 per cent in different countries (7). 
General principles of DKA treatment are determined by the character of disturbances oc-
curred. They include as follows: normalization of metabolic disorders (mainly of carbohydrate 
one) by means of insulin therapy and restoration of glucose (glycogen) reserves in the organism; 
correction of water-electrolyte deficiency; elimination of acid-base disbalance; symptomatic 
treatment of functional disorders of different organs and systems accompanying (or preceding 
or having caused) diabetic coma. 
Until recently, maximally rapid eliminatron of all disturbances was considered a basic prin-
ciple of behaviour. That was why during the first hour of DKA an intensive insulin treatment at 
dosis of 80—300 U of rapidly acting insulin was carried out. However, the long experience in 
the last decade caused essential changes in the tactics of DKA treatment. The new principles of 
DKA treatment are realized mainly by means of administration of low insulin doses. In 1973, 
Alberti et al. (5) first introduced this method of DKA treatment. Recent investigations correct-
ed many of the traditional concepts about DKA pathogenesis and the mechanism of insulin 
influence in this case. It was demonstrated that in numerous DKA cases and as a rule in the 
cases of hyperosmolar coma a high sensitivity to insulin was presented (6 ,8) . 
Material and Methods 
Since 1975, we introduced DKA treatment by using crystal insulin infusions at low doses ac-
cording to an unified therapeutic schedule in the Clinic of Endocrinology of the Higher Institu-
te of Medicine, Varna: venous dropwise crystal insulin "Pharmachim" infusion diluted in saline 
(3, 4). Crystal insulin amount was 8 U /500 ml/ hour during the first 6 hours each and then 
20 U / 500 ml / 3 hours each. No human albumin was applied. Since the third hour of treat-
ment, potassium preparations (potassium chloride or panangin) were intravenously admi-
nistered and the amount of potassium introduced was in conformity with kaliemia established. 
Mean potassium level administered was 15-20 mMol/1. If, however, during DKA treatment hy-
pokaliemia occurred and blood potassium level reduced below 3.5 mMol/1 then injection speed 
of 2 per cent potassium cliloride solution should be increased up to 40—50 mMol/hour (100 
ml/hour). 
Rehydratation was performed by physiological saline when blood glucose level was over 12 
mMol/1 (250 mg%) and by glucose serum when this level was below 13 mMol/1 (250 m%). 
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Drug treatment of acidosis was administered at pH below 7.2:50 mMol (150 ml of 2.74 per 
cent sodium bicarbonate solution) were intravenously injected for 30 min. When pH was below 
7.0, a total of 125 mMol (375 ml of this solution) were injected (3). 
Results and Discussion 
A total of 1340 DKA patients were treated after this method during a 10-year period. This 
number presented 42 per cent of all diabetes mellitus patients hospitalized in the Clinic. There 
were 547 males and 793 females. The way of treatment prior to DKA appearance was as fol­
lowed: insulin therapy - in 828 patients, peroral one - in 440 while diet failute was in 32 pa­
tients and 40 cases were of newly-diagnosed diabetes mellitus. After treatment by our method 
blood glucose level reduced relatively rapidlier in the first 3 hours and then decreased gradually 
reaching its minimum of about 10 mMol/1 on the 6 t h - 8 m hour (fig. 1). This slow and gradual 
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Fig. 1. Glycemia dynamics during treatment 
glucose level reduction is favourable for the patients because it excludes the risk of hypoglyce­
mia and decreases the danger of sharp changes in the water-electrolyte balance. We do not use 
human albumin. This does not alter the effectiveness of the treatment but it reduces consider­
ably therapeutic costs. In 1976, i.e. one year after introduction of this method by us, Peter­
son et al. (cited after 1) confute previous apprehensions that 1/4 of intravenously injected in­
sulin retains on the wall of the bank and system tubules for infusions. These authors indicate 
that during infusion of the initial 50 ml of the fluid containing less than 0.1 U/ml insulin a com­
plete saturation of absorption surfaces of the system sets in thus a'further insulin loss is inter­
rupted. 
DKA was overcome in all the patients without any exception after the treatment carried cut 
according to our schedule: disappearance of ketobodies in urine and blood sugar level reduc­
tion. However, the later results depended on the main disease inducing DKA (fig. 2). Of our pa­
tients, 1121 could compensate the diabetes mellitus and 119 ones died. The cardinal causes for 
lethal outcome were as followed: brain oedema in patients with severe cerebral circulation dis­
orders and with severe water-electrolyte ones; acute cardiovascular accidents on the background 
of manifested ischemic heart disease; infectious-septic diseases; advanced chronic renal fai­
lure, etc. 
Mean DKA duration was 8 hours. This period was shorter in patients with dietary errors and 
lapses in the treatment.(at the average 6 hours) and most long-lasting in patients with bacterial 
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Fig. 2. Causes for DKA. 
and viral infections (at the average 12 hours) while other cases occupied an intermediate posi­
tion. Insulin dosage required to overcome DKA was presented on fig. 3. 
We examined also some other biochemical parameters altered unfavourably by DKA. First 
they were coagulation changes. There was a tendency towards hypercoagulation due tohaemo-
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Fig. 4 . Changes of fibrin-degradation products in DKA. 
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concentration in a case of ketoacidosis combined with metabolic and coagulation disturbances, 
These alterations were risk factors for intravascular coagulation and that was why we routinely 
used in our practice heparin in low doses when pH was below 7.2 (fig. 4) c Low heparin doses 
were recommended as prophylaxis against thromboembolic complications (7). This therapy had 
insignificant side effects. 
Lipid metabolism was also influenced favourably by от therapy. According to от data, ke­
toacidosis was characterized by lipid profile deviation in direction'to prevalence of atherogenic 
lipoproteins and fatty acids. This therapy resulted in diminishing this trend and changing the 
lipid profile into an antiatherogenic directioE (fig. 5). 
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F i e 5. Changes of atherogenic index in DKA. 
Third some changes set in in the renin-angiotensin-aldosterone system which was strongly 
activated in DKA. Plasma renin activity and urine aldosterone excretion elevated repeatedly. 
Although these changes were compensatory concerning dehydratation they could influence un­
favourably on the cardiovascular system functioning and worsen electrolyte disorders, especial­
ly hypokaliemia. After treatment renin activity normalized and acetonuria disappeared while 
increased urinary aldosterone reduced slowlier and remained over the normal level after aceto­
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Fig, 6. Dynamics of renin-aldosterone secretion in DKA. 
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lize sodium and potassium monitoring and to perform a corresponding substitution therapy 
with potassium during the period after acetonuria disappearance, too. 
The following conclusions can be drawn on the basis of our investigations: 
1. At presence, D K A treatment with low-dosis crystal insulin is a method of choice. This 
method is very effective and results not only in acetonuria disappearance and hyperglycemia 
overcoming but also in elimination of other secondary metabolic disturbances. 
2. Hypercoagulation due to haemoconcentration is a risk factor for intravascular coagulation 
in D K A cases and it is corrected by adequate therapy and administration of low heparin doses 
at pH below 7.2. 
3. DKA treatment according to this schedule induces changes of lipid profile in an anti­
atherogenic direction. 
4. The strong activation of renin-angiotensin-aldosterone system in DKA requires sodium 
and potassium monitoring and substitution therapy by potassium preparations even after ace­
tonuria disappearance. 
5. The strongest efforts to reduce the danger of development of D K A should be directed to 
its prevention by means of education of both physicians and diabetes mellitus patients. 
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Р Е З Ю М Е 
Сообщаются результаты десятилетнего опыта к л и н и к и э н д о к р и н о л о г и и при В ы с ш е м медицин­
с к о м институте в Варне, полученных при лечении диабетического кетоацидоза , п р и м е н е н н о м 1340 
б о л ь н ы м сахарным диабетом. Создана единая терапевтическая схема: в е н о з н а я капельная и н ф у з и я 
м а л ы х д о з кристаллического инсулина. Г л и к е м и я понижается медленно и постепенно, что и с к л ю ­
чает р и с к г и п о г л и к е м и и и уменьшает опастность в р е з к и х сдвигах водно-электролитного равнове ­
сия. Соответственно у р о в н ю к а л и я применяются соответствующие к о р р е к ц и и х л о р и д о м к а л и я , 
/ щ и д о з подвергается в л и я н и ю бикарбоната натрия л и ш ь в случае, что рН ниже 7,2. При тех же 
стоимосгях рН применяются м а л ы е д о з ы гепарина с целью предупреждения т р о м б о э м б о л и ч е с к и х 
осложнений. При диабетическом кетоацидозе сильно а к т и в и р у е т с я ренин-ангиотензин-альдосте-
роновая система. Это приводит к необходимости в з а м е щ а ю щ е й терапии к а л и е м и в период после 
исчезновения ацетона в моче. П р и м е н я е м а я а в т о р а м и лечебная ^ х е м а д л я лечения диабетического 
кетоацедоза я в л я е т с я внедрением чужого опыта с т в о р ч е с к и м и м о д и ф и к а ц и я м и , к о т о р ы е привели 
к определенному э к о н о м и ч е с к у э ф ф е к т у . Описанная схема внедрена в лечебную практиту всех боль­
ниц Сев еро во сточной Б о л г а р и и . 
